Adverum Biotechnologies Stock Annual Yield
| ADVM Stock | USD 2.32 0.07 2.93% |
Fundamental analysis of Adverum Biotechnologies allows traders to better anticipate movements in Adverum Biotechnologies' stock price by examining its financial health and performance throughout various phases of its business cycle.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Adverum Biotechnologies Company Annual Yield Analysis
Adverum Biotechnologies' Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
| Competition |
In accordance with the recently published financial statements, Adverum Biotechnologies has an Annual Yield of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Companies Directory Now
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
| All Next | Launch Module |
Adverum Fundamentals
| Return On Equity | -1.45 | ||||
| Return On Asset | -0.49 | ||||
| Operating Margin | (158.18) % | ||||
| Current Valuation | 58.35 M | ||||
| Shares Outstanding | 20.89 M | ||||
| Shares Owned By Insiders | 13.10 % | ||||
| Shares Owned By Institutions | 79.43 % | ||||
| Number Of Shares Shorted | 1.03 M | ||||
| Price To Earning | (2.10) X | ||||
| Price To Book | 1.83 X | ||||
| Price To Sales | 49.94 X | ||||
| Revenue | 1000 K | ||||
| Gross Profit | (89.38 M) | ||||
| EBITDA | (127.27 M) | ||||
| Net Income | (130.93 M) | ||||
| Cash And Equivalents | 235.84 M | ||||
| Cash Per Share | 2.37 X | ||||
| Total Debt | 91.7 M | ||||
| Debt To Equity | 0.43 % | ||||
| Current Ratio | 8.03 X | ||||
| Book Value Per Share | 1.26 X | ||||
| Cash Flow From Operations | (92.46 M) | ||||
| Short Ratio | 3.34 X | ||||
| Earnings Per Share | (7.22) X | ||||
| Target Price | 19.75 | ||||
| Number Of Employees | 155 | ||||
| Beta | 0.7 | ||||
| Market Capitalization | 49.94 M | ||||
| Total Asset | 179.84 M | ||||
| Retained Earnings | (1.07 B) | ||||
| Working Capital | 108.4 M | ||||
| Current Asset | 260.99 M | ||||
| Current Liabilities | 6.57 M | ||||
| Net Asset | 179.84 M |
About Adverum Biotechnologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Adverum Biotechnologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Adverum Biotechnologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Adverum Biotechnologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Adverum Biotechnologies Piotroski F Score and Adverum Biotechnologies Altman Z Score analysis. To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adverum Biotechnologies. If investors know Adverum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adverum Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Adverum Biotechnologies is measured differently than its book value, which is the value of Adverum that is recorded on the company's balance sheet. Investors also form their own opinion of Adverum Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adverum Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adverum Biotechnologies' market value can be influenced by many factors that don't directly affect Adverum Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adverum Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adverum Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adverum Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.